Navigation Links
Neogen Corporation Announces 2nd Quarter Results Conference Call
Date:12/22/2010

LANSING, Mich., Dec. 22, 2010 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announces the following Webcast:What:

Neogen Corporation 2nd Q Results WebcastWhen:

Tuesday, January 4, 2011 @ 11:00 ETWhere:

http://www.videonewswire.com/event.asp?id=75037How:

Live over the Internet -- Simply log on to the web at the address above.  Contact:  

Terry Maynard of Neogen Corporation, +1-800-234-5333.If you are unable to participate during the live webcast, the call will be archived on the Web site www.neogen.com.

Neogen Corporation develops and markets products and services dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, unique proteins, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.


'/>"/>
SOURCE Neogen Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neogens Rapid Test for Salmonella enteritidis Receives AOAC Approval
2. NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010
3. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
4. Neogen Corporation Announces 3rd Quarter Results Conference Call
5. Neogen Reports 18% Increase in Net Income
6. Richard T. Crowder Joins Neogens Board of Directors
7. Neogen Announces 3 for-2 Stock Split
8. Neogen to Ring NASDAQs Closing Bell
9. NeoGenomics To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 18, 2009
10. Neogen Again Named to Forbes List of Best Small Companies
11. Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... SHANGHAI , Jan. 19, 2017 /PRNewswire -- ... medical device open-access capability and technology platform, today ... a leading biology focused preclinical drug discovery contract ... Biosciences will become a wholly-owned subsidiary of WuXi, ... core competences and providing greater services. The acquisition ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., today ... , Ph.D., as chief executive officer, as well ... Dr. Schmidt brings to ArmaGen more than 17 years ... and development of biotherapeutics and pharmaceuticals. ... the diverse experience and skillset necessary to lead ...
(Date:1/19/2017)... Minneapolis, Minnesota (PRWEB) , ... January 19, 2017 ... ... contract research organization with services spanning the full spectrum of drug and device ... clinical research services to pharma/device companies and clinicians, today announced Verified Clinical ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 USB 3.0 ... E FPGA into a compact business-card sized form factor suitable for prototyping, testing, ...
Breaking Biology Technology:
(Date:1/6/2017)... 2017  Delta ID Inc., a leader in consumer-grade ... automotive at CES® 2017. Delta ID has collaborated with ... the use of iris scanning as a secure, reliable ... in a car, and as a way to elevate ... Delta ID and Gentex will demonstrate (booth #7326 ...
(Date:12/22/2016)... Dec. 20, 2016  As part of its longstanding mission ... personal genetics company, recently released its latest children,s book, titled ... book focuses on the topics of inheritance and variation of ... (NGSS) taught in elementary school classrooms in the US. ... by illustrator Ariana Killoran , whose previous book with ...
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
Breaking Biology News(10 mins):